Betamethasone Acetate/Betamethasone Sodium Phosphate Suspension for Injection Shortage
Last Updated: April 27, 2023
Status: Current
Products Affected - Description
-
- Betamethasone acetate/betamethasone sodium phosphate suspension for injection, Exela Pharma Sciences, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 51754-5060-01 - discontinued
Reason for the Shortage
-
- American Regent did not provide a reason for the shortage.
- Exela discontinued betamethasone injection in mid-February 2023.
- Organon did not provide a reason for the shortage.
Available Products
-
- Celestone Soluspan suspension for injection, Organon, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 78206-0118-01
- Betamethasone acetate/betamethasone sodium phosphate suspension for injection, American Regent, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00517-0720-01
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated April 27, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 1, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.